|
|
||||||||
-Adrenergic receptor/cAMP-mediated signaling and apoptosis
of S49 lymphoma cells
Department of Pharmacology, University of California, San Diego, La Jolla, California 92093-0636
-Adrenergic receptor (
AR) activation
and/or increases in cAMP regulate growth and proliferation of a variety
of cells and, in some cells, promote cell death. In the current studies
we addressed the mechanism of this growth reduction by examining
AR-mediated effects in the murine T-lymphoma cell line S49.
Wild-type S49 cells, derived from immature thymocytes
(CD4+/CD8+) undergo growth arrest and
subsequent death when treated with agents that increase cAMP levels
(e.g.,
AR agonists, 8-bromo-cAMP, cholera toxin, forskolin).
Morphological and biochemical criteria indicate that this cell death is
a result of apoptosis. In cyc
and kin
S49
cells, which lack Gs
and functional protein kinase A
(PKA), respectively,
AR activation of Gs
and cAMP
action via PKA are critical steps in this apoptotic pathway. S49 cells
that overexpress Bcl-2 are resistant to cAMP-induced apoptosis. We
conclude that
AR activation induces apoptosis in immature T
lymphocytes via Gs
and PKA, while overexpression of
Bcl-2 prevents cell death.
AR/cAMP/PKA-mediated apoptosis may
provide a means to control proliferation of immature T cells in vivo.
programmed cell death; protein kinase A; forskolin; Gs
This article has been cited by other articles:
![]() |
U. H. Frey, H. Nuckel, L. Sellmann, D. Siemer, R. Kuppers, J. Durig, U. Duhrsen, and W. Siffert The GNAS1 T393C Polymorphism Is Associated with Disease Progression and Survival in Chronic Lymphocytic Leukemia. Clin. Cancer Res., October 1, 2006; 12(19): 5686 - 5692. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. H. Frey, H. Alakus, J. Wohlschlaeger, K. J. Schmitz, G. Winde, H. G. van Calker, K.-H. Jockel, W. Siffert, and K. W. Schmid GNAS1 T393C Polymorphism and Survival in Patients with Sporadic Colorectal Cancer Clin. Cancer Res., July 15, 2005; 11(14): 5071 - 5077. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. H. Frey, A. Eisenhardt, G. Lummen, H. Rubben, K.-H. Jockel, K. W. Schmid, and W. Siffert The T393C Polymorphism of the G{alpha}s Gene (GNAS1) Is a Novel Prognostic Marker in Bladder Cancer Cancer Epidemiol. Biomarkers Prev., April 1, 2005; 14(4): 871 - 877. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-P. Huang, X. Song, H.-Y. Wang, and C. C. Malbon Targeted expression of activated Q227L Galpha s in vivo Am J Physiol Cell Physiol, August 1, 2002; 283(2): C386 - C395. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Yusta, J. Estall, and D. J. Drucker Glucagon-like Peptide-2 Receptor Activation Engages Bad and Glycogen Synthase Kinase-3 in a Protein Kinase A-dependent Manner and Prevents Apoptosis following Inhibition of Phosphatidylinositol 3-Kinase J. Biol. Chem., July 5, 2002; 277(28): 24896 - 24906. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zhang and P. A. Insel Bcl-2 protects lymphoma cells from apoptosis but not growth arrest promoted by cAMP and dexamethasone Am J Physiol Cell Physiol, November 1, 2001; 281(5): C1642 - C1647. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |